Idiopathic sporadic tumoral calcinosis of the hip: Successful oral bisphosphonate therapy

Endocrine Practice

Volumn 13, Issue 2, 2007, Pages 182-186

  Jacob, Jubbin Jagan ^a   Mathew, Kusum ^b   Thomas, Nihal ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENT; CALCIUM; CREATININE; PHOSPHATE;

ARTHROPATHY; ARTICLE; BLOOD; CALCINOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; HIP; HUMAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; RADIOGRAPHY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ALENDRONATE; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; CALCIUM; CREATININE; FEMALE; HIP JOINT; HUMANS; JOINT DISEASES; MIDDLE AGED; PHOSPHATES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34447320516     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.2.182     Document Type: Article

References (22)

1. Inclan A, Leon P, Gomez CM. Tumoral calcinosis. JAMA. 1943;121:490-495.
2. Teutschlaender O. Ueber progressive Lipogranulomatose der Muskulatur. Klin Wschr. 1935;14:451-453.
3. Slavin RE, Wen J, Kumar D, Evans EB. Familial tumoral calcinosis: a clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis. Am J Surg Pathol. 1993;17:788-802.
4. Nunley JR, Jones LME. Calcinosis cutis. Available at: http://www.emedicine.com. Accessed for verification June 14, 2006.
5. Campanacci M. Bone and Soft Tissue Tumors. New York, NY: Springer Verlag, 1990: 1098-1101.
6. Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet. 2005;14:385-390.
7. Larsson T, Yu X, Davis SI, et al. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab. 2005;90:2424-2427.
8. de Beur SM. Tumoral calcinosis: a look into the metabolic mirror of phosphate homeostasis. J Clin Endocrinol Metab. 2005;90:2469-2471.
9. Hammoud S, McCarthy EF, Weber K. Tumoral calcinosis in infants: a report of three cases and review of the literature. Clin Orthop Relat Res. 2005;436:261-264.
10. Thakur A, Hines OJ, Thakur V, Gordon HE. Tumoral calcinosis regression after subtotal parathyroidectomy: a case presentation and review of the literature. Surgery. 1999;126:95-98.
11. Zins B, Zingraff J, Basile C, et al. Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication. Nephron. 1992;60:260-267.
12. Cannata-Andia JB, Drueke TB, Cunningham J, et al. Clinical algorithms on renal osteodystrophy: report of an expert working group. Nephrol Dial Transplant. 2000; 15(Suppl 5):39-57.
13. de Francisco AM, Ellis HA, Owen JP, et al. Parathyroidectomy in chronic renal failure. Q J Med. 1985; 55:289-315.
14. Yamaguchi T, Sugimoto T, Imai Y, Fukase M, Fujita T, Chihara K. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone. 1995;16(4 Suppl):247S-250S.
15. Francis MD, Russell RG, Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. 1969;165:1264-1266.
16. Zucchelli P, Fusaroli M, Fabbri L, et al. Treatment of ectopic calcification in uremia. Kidney Int Suppl. 1978;8: S86-S90.
17. Naito T, Nitta K, Kimata N, Honda K, et al. Progressive tumoral calcinosis as the presenting feature of sarcoidosis in a patient on haemodialysis treatment. Nephrol Dial Transplant. 1999;14:2716-2719.
18. Kuriyama S, Tomonari H, Nakayama M, Kawaguchi Y, Sakai O. Successful treatment of tumoral calcinosis using CAPD combined with hemodialysis with low-calcium dialysate. Blood Purif. 1998;16:43-48.
19. Phanish MK, Kallarackal G, Ravanan R, Lawson TM, Baboolal K. Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant. 2000;15:1691-1693.
20. Fleisch H. Mechanisms of action of the bisphosphonates. Medicina (B Aires). 1997;57(Suppl 1):65-75.
21. Niall DM, Fogarty EE, Dowling FE, Moore DP. Spontaneous regression of tumoral calcinosis in an infant: a case report. J Pediatr Surg. 1998;33:1429-1431.
22. Steinbach LS, Johnston JO, Tepper EF, Honda GD, Martel W. Tumoral calcinosis: radiologic-pathologic correlation. Skeletal Radiol. 1995;24:573-578.